Medline Inc. 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of Medline Inc.'s 2026 Annual Meeting of Stockholders held on June 11, 2026. The filing details the outcomes of four key proposals submitted to security holders, including the election of directors, executive compensation votes, and auditor ratification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Stockholders voted on the following matters with the results summarized below:
- Election of Directors: All 12 nominees were elected to serve one-year terms expiring at the 2027 Annual Meeting. While all were approved, nominee Robert R. Schmidt received the highest number of withheld votes (43,976,750) compared to other nominees.
- Executive Compensation (Say-on-Pay): Stockholders approved the advisory vote on executive compensation with 1,189,280,399 shares voting "For" and 6,203,145 shares voting "Against."
- Frequency of Compensation Votes: Stockholders approved holding advisory votes on executive compensation annually (one-year frequency), receiving 1,195,424,539 "For" votes.
- Auditor Ratification: Stockholders ratified the selection of Ernst & Young LLP as the independent auditor for the fiscal year ending December 31, 2026, with 1,211,242,117 shares voting "For."
Guidance, Outlook, and Management Commentary
Management confirmed that the Company will hold an advisory stockholder vote on executive compensation every year, consistent with the Board of Directors' recommendation. No financial guidance, risk factors, or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the specific reasons for the elevated "withheld" votes for director nominee Robert R. Schmidt compared to other nominees.
- Review the full proxy statement filed on April 23, 2026, for detailed biographies of the elected directors and executive compensation specifics.
- Confirm the upcoming fiscal year-end date of December 31, 2026, for future financial reporting expectations.